EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”

Mark Chandy iD, Thomas Hill iD, Nerea Jimenez-Tellez iD, Joseph C Wu iD, S Emma Sarles iD, Edward Hensel iD, Qixin Wang iD, Irfan Rahman iD, Daniel J Conklin iD

Cardiovascular Toxicology · 2024

DOI: 10.1007/s12012-024-09850-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Toxicology, 2024. Verfasst von Mark Chandy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Robarts Research Institute, Western University, London, N6A 5K8, Canada. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Cardiovascular Diseases, Vaping. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cigarette smoking is positively and robustly associated with cardiovascular disease (CVD), including hypertension, atherosclerosis, cardiac arrhythmias, stroke, thromboembolism, myocardial infarctions, and heart failure. However, after more than a decade of ENDS presence in the U.S. marketplace, uncertainty persists regarding the long-term health consequences of ENDS use for CVD. New approach methods (NAMs) in the field of toxicology are being developed to enhance rapid prediction of human health hazards. Recent technical advances can now consider impact of biological factors such as sex and race/ethnicity, permitting application of NAMs findings to health equity and environmental justice issues. This has been the case for hazard assessments of drugs and environmental chemicals in areas such as cardiovascular, respiratory, and developmental toxicity. Despite these advances, a shortage of widely accepted methodologies to predict the impact of ENDS use on human health slows the application of regulatory oversight and the protection of public health. Minimizing the time between the emergence of risk (e.g., ENDS use) and the administration of well-founded regulatory policy requires thoughtful consideration of the currently available sources of data, their applicability to the prediction of health outcomes, and whether these available data streams are enough to support an actionable decision. This challenge forms the basis of this white paper on how best to reveal potential toxicities of ENDS use in the human cardiovascular system-a primary target of conventional tobacco smoking. We identify current approaches used to evaluate the impacts of tobacco on cardiovascular health, in particular emerging techniques that replace, reduce, and refine slower and more costly animal models with NAMs platforms that can be applied to tobacco regulatory science. The limitations of these emerging platforms are addressed, and systems biology approaches to close the knowledge gap between traditional models and NAMs are proposed. It is hoped that these suggestions and their adoption within the greater scientific community will result in fresh data streams that will support and enhance the scientific evaluation and subsequent decision-making of tobacco regulatory agencies worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Nicotine Delivery SystemsCardiovascular DiseasesVapingHumansRisk AssessmentAnimalsRisk FactorsNicotineNicotinic AgonistsConsumer Product SafetyCardiovascular SystemCardiotoxicityHeart Disease Risk FactorsE-Cigarette Vapor

Stichwörter der Autor:innen

CardiotoxicityElectronic cigarettesEndothelial dysfunctionInduce pluripotent stem cellsNew approach methodsNicotineTobacco

Substanzen

NicotineNicotinic AgonistsE-Cigarette Vapor

Autor:innen und Institutionen

  • Robarts Research Institute, Western University, London, N6A 5K8, Canada.
  • Division of Nonclinical Science, Center for Tobacco Products, US Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, 94304, USA.
  • Biomedical and Chemical Engineering PhD Program, Rochester Institute of Technology, Rochester, NY, 14623, USA.
  • Department of Mechanical Engineering, Rochester Institute of Technology, Rochester, NY, 14623, USA.

ORCID-Profile: Mark Chandy, Thomas Hill, Nerea Jimenez-Tellez, Joseph C Wu, S Emma Sarles, Edward Hensel, Qixin Wang, Irfan Rahman, Daniel J Conklin

Förderung

  • NIEHS NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • NIDA NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • American Heart Association

Zitieren

APA

Chandy, M., Hill, T., Jimenez-Tellez, N., Wu, J. C., Sarles, S. E., Hensel, E., Wang, Q., Rahman, I., & Conklin, D. J. (2024). Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09850-9

Vancouver

Chandy M, Hill T, Jimenez-Tellez N, Wu JC, Sarles SE, Hensel E, et al. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”. Cardiovascular Toxicology. 2024. doi:10.1007/s12012-024-09850-9

BibTeX
@article{Chandy2024,
  author = {Chandy, Mark and Hill, Thomas and Jimenez-Tellez, Nerea and Wu, Joseph C and Sarles, S Emma and Hensel, Edward and Wang, Qixin and Rahman, Irfan and Conklin, Daniel J},
  title = {Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”},
  journal = {Cardiovascular Toxicology},
  year = {2024},
  doi = {10.1007/s12012-024-09850-9}
}
Kostenlos starten →